Oncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell Cancers

Simple item page
dc.contributor.authorGokalp, F
dc.contributor.authorCelik, S
dc.contributor.authorSozen, TS
dc.contributor.authorOzen, AH
dc.contributor.authorAslan, G
dc.contributor.authorIzol, V
dc.contributor.authorBaltaci, S
dc.contributor.authorMuezzinoglu, T
dc.contributor.authorAkdogan, B
dc.contributor.authorSuer, E
dc.contributor.authorTinay, I
dc.date.accessioned2024-07-18T12:07:47Z
dc.date.available2024-07-18T12:07:47Z
dc.description.abstractPurpose: We aimed to compare oncological outcomes in the two rare subtypes, unclassified renal cell cancer (un-RCC) and translocation RCC (tRCC), vs clear cell RCC (ccRCC). Materials and Methods: Between 2004 and 2019, from Turkish Urooncology Society Database, we identified 2324 patients for histological subtypes including 80 unRCC (3.4%), 19 tRCC (0.8%) and 2225 ccRCC (95.8%). Results: The overall (15.8%) and cancer-specific mortalities (11.1%) were found to be higher in tRCC group and the recurrence free mortality (13.8%) was found to be higher in unRCC group. Larger pathological tumor size (p = 0.012) and advanced pathological T stage (p = 0.042) were independent predictive factors on overall mortality in patients with unRCC tumors. Conclusion: The oncological outcomes of the unRCC and tRCC are worse than ccRCC and pathological tumor size and pathological stage are predictive factors for mortality in the unRCC.
dc.identifier.issn1735-1308
dc.identifier.other1735-546X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10641
dc.language.isoEnglish
dc.publisherUROL & NEPHROL RES CTR-UNRC
dc.subjectPROGNOSTIC IMPACT
dc.subjectCARCINOMA IMPACT
dc.titleOncological Outcomes of Patients with Non-Clear Cell Renal Cell Cancers: Subtypes of Unclassified and Translocation Renal Cell Cancers
dc.typeArticle

Files

Collections

Web of Science Koleksiyonu